Cantor Fitzgerald Starts Seres Therapeutics (MCRB) at Overweight
Tweet
Share
E-mailGet Alerts MCRB Hot Sheet
Price: $4.56 -0.22%
Rating Summary:
9 Buy, 3 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
9 Buy, 3 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Cantor Fitzgerald initiated coverage on Seres Therapeutics (NASDAQ: MCRB) with an Overweight rating and a price target of $16.00.
For an analyst ratings summary and ratings history on Seres Therapeutics click here. For more ratings news on Seres Therapeutics click here.
Shares of Seres Therapeutics closed at $9.20 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cantor Fitzgerald Starts Nuvation Bio Inc (NUVB) at Overweight
- CrowdStrike (CRWD) PT Adjusted $250 at Cantor Fitzgerald Post Stock Split
- TD Cowen Assumes Sana Biotechnology (SANA) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
